Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group

Hypertension (HTN) is frequently associated with the use of angiogenesis inhibitors targeting the vascular endothelial growth factor pathway and appears to be a generalized effect of this class of agent. We investigated the phenomenon in 61 patients with advanced hepatocellular carcinoma (HCC) recei...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Clinical Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924783/
https://ncbi.nlm.nih.gov/pubmed/26893366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7444
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky